Simulations Plus

Simulations Plus Goodwill

The Goodwill of Simulations Plus (SLP) as of Oct 3, 2026 is 43.72 M USD. In the previous year, Goodwill was 96.08 M USD — a change of -54.50% (lower).

Goodwill

43.72 MUSD

YoY

-54.50%

Last updated:

Goodwill of Simulations Plus is 2026 43.72 M USD. Goodwill of Simulations Plus was 2025 96.08 M USD. It decreases by -54.50% lower compared to the previous year.

The Simulations Plus Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2018
10.39 M USD
Jan 1, 2019
10.39 M USD
Jan 1, 2020
12.92 M USD
Jan 1, 2021
12.92 M USD
Jan 1, 2022
12.92 M USD
Jan 1, 2023
19.10 M USD
Jan 1, 2024
96.08 M USD
Jan 1, 2025
43.72 M USD
The Simulations Plus Goodwill history
YEARGoodwillYoY
43.72 MUSD-54.50%
96.08 MUSD+403.05%
19.10 MUSD+47.81%
12.92 MUSD0.00%
12.92 MUSD-0.00%
12.92 MUSD+24.40%
10.39 MUSD0.00%
10.39 MUSD0.00%
10.39 MUSD+116.89%
4.79 MUSD0.00%
4.79 MUSD—
0.00USD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Goodwill of Simulations Plus is 43.72 M USD in 2026.

Goodwill of Simulations Plus changed from 96.08 M USD to 43.72 M USD, representing a -54.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus